| General Information of Drug Metabolite (DM) (ID: DM018661) |
| DM Name |
Maraviroc Metabolite H12,H13
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A (CYP3A)
|
DMEN065
|
| Oxidation - Mono-oxidation |
Maraviroc
|
[1] |
|
|
|
|
|
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A (CYP3A)
|
DMEN065
|
| Oxidation - Mono-oxidation |
Maraviroc
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Maraviroc |
DR5276
|
Approved |
Human immunodeficiency virus infection |
|
|
| References |
| 1 |
Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
